Dynamics of adaptive immunity against phage in bacterial populations
Serena Bradde, Marija Vucelja, Tiberiu Tesileanu, Vijay, Balasubramanian

TL;DR
This paper develops a population dynamical model of bacterial CRISPR immunity, revealing how spacer acquisition and effectiveness influence bacterial-phage coexistence, oscillations, and diversity in spacer populations.
Contribution
It introduces a novel dynamical model incorporating acquisition and loss of immunity, providing insights into spacer diversity and population dynamics.
Findings
High acquisition probability leads to diverse spacer populations.
Spacer effectiveness results in peaked, winner-take-all distributions.
Bacteria can tune acquisition probability to control spacer diversity.
Abstract
The CRISPR (clustered regularly interspaced short palindromic repeats) mechanism allows bacteria to adaptively defend against phages by acquiring short genomic sequences (spacers) that target specific sequences in the viral genome. We propose a population dynamical model where immunity can be both acquired and lost. The model predicts regimes where bacterial and phage populations can co-exist, others where the populations exhibit damped oscillations, and still others where one population is driven to extinction. Our model considers two key parameters: (1) ease of acquisition and (2) spacer effectiveness in conferring immunity. Analytical calculations and numerical simulations show that if spacers differ mainly in ease of acquisition, or if the probability of acquiring them is sufficiently high, bacteria develop a diverse population of spacers. On the other hand, if spacers differ mainly…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsBacteriophages and microbial interactions · Evolution and Genetic Dynamics · HIV Research and Treatment
